Description
Dazmet-G1 Tablets – Glimepiride & Metformin SR Tablets for Diabetes Management
Diabetes and uncontrolled blood sugar levels are among the most common chronic health concerns affecting millions of people worldwide. Poor lifestyle habits, obesity, stress, unhealthy eating patterns, reduced physical activity, and metabolic imbalance may contribute to elevated blood glucose levels and long-term diabetic complications.
Dazmet-G1 Tablets are an advanced anti-diabetic formulation containing glimepiride 1 mg and metformin hydrochloride SR 500 mg. The combination is widely used for blood sugar management and glycaemic control in type 2 diabetes mellitus under medical supervision.
Its dual-action anti-diabetic formulation helps support better glucose utilisation and blood sugar balance, making Dazmet-G1 Tablets highly preferred in diabetic healthcare management.
Dazmet-G1 Tablets are manufactured by Dazzle Healthcare under quality-controlled pharmaceutical manufacturing standards to ensure healthcare safety, reliability, and effectiveness.
What are Dazmet-G1 tablets?
Dazmet-G1 Tablets are anti-diabetic tablets formulated with glimepiride and metformin hydrochloride sustained release. The combination is commonly prescribed for the management of type 2 diabetes mellitus along with proper diet and lifestyle management.
The formulation helps support blood glucose control through dual mechanisms and is widely preferred for diabetic wellness support.
Its sustained-release formulation helps maintain better therapeutic effectiveness and patient compliance.
Product Information
| Product Details | Information |
| Brand Name | Dazmet-G1 Tablets |
| Composition | Glimepiride 1mg + Metformin 500mg SR |
| Dosage Form | Tablets |
| Packing Size | 10×10 Tablets |
| Category | Anti-Diabetic Tablets |
| Usage | Blood Sugar Management |
| Manufacturer | Dazzle Healthcare |
Composition of Dazmet-G1 Tablets
Glimepiride 1 mg
Glimepiride belongs to the sulfonylurea class of antidiabetic medicines. It helps stimulate insulin release from the pancreas and supports blood sugar control.
Metformin Hydrochloride SR 500mg
Metformin helps improve insulin sensitivity and reduces glucose production in the liver. The sustained-release formulation helps provide prolonged therapeutic action and better glycaemic management.
How Dazmet-G1 Tablets Work
Dazmet-G1 tablets work through a dual anti-diabetic mechanism.
Glimepiride helps increase insulin secretion from pancreatic beta cells, while metformin helps improve insulin sensitivity and reduces hepatic glucose production. Together, the combination helps maintain balanced blood sugar levels and supports diabetic wellness management.
The sustained-release formulation helps improve therapeutic effectiveness and patient compliance.
Uses of Dazmet-G1 Tablets
Dazmet-G1 Tablets are commonly used for:
- Type 2 Diabetes Mellitus management
- Blood sugar control support
- Glycemic management
- Insulin resistance support
- Diabetic wellness management
- Metabolic balance support
- Oral anti-diabetic therapy
- Long-term diabetic healthcare support
Benefits of Dazmet-G1 Tablets
Key Benefits
- Helps support blood sugar management
- Dual-action anti-diabetic formulation
- Sustained-release therapeutic support
- Helps improve insulin sensitivity
- Supports glycemic balance
- Convenient oral tablet dosage form
- Supports diabetic wellness management
- Suitable for long-term diabetic care under supervision
Importance of Blood Sugar Management
Maintaining healthy blood glucose levels is important for overall wellness and prevention of diabetic complications. Poor blood sugar management may affect multiple organs and overall quality of life.
Proper diabetic management with lifestyle modifications, healthy nutrition, physical activity, and anti-diabetic therapy helps support long-term wellness and metabolic health.
The increasing prevalence of diabetes continues to drive strong demand for effective anti-diabetic healthcare products across India.
Why Dazmet-G1 Tablets are a High-Demand Product
The anti-diabetic healthcare segment continues to grow rapidly because of increasing diabetes awareness and rising diabetic healthcare needs.
Dazmet-G1 tablets are highly preferred because of:
- Dual-action anti-diabetic combination
- Sustained-release formulation
- Strong blood sugar management support
- High-demand diabetic category
- Broad healthcare usage
- Strong pharmaceutical market demand
Its strong diabetic healthcare relevance makes it commercially valuable in the pharmaceutical market.
Dosage and Administration
Dazmet-G1 Tablets should be used strictly under medical supervision.
Usage Instructions
- Use as advised by the physician
- Swallow the tablet with water
- Do not exceed the recommended dosage
- Maintain a healthy diet and exercise routine
- Store in a cool and dry place
Dosage may vary depending on the diabetic condition and patient requirements.
Safety and Precautions
Important Precautions
- Use only under healthcare supervision
- Monitor blood sugar levels regularly
- Follow diabetic diet and exercise recommendations
- Inform the doctor about existing medical conditions
- Do not self-medicate
Some individuals may experience mild gastrointestinal discomfort, dizziness, or low blood sugar symptoms. Consult a healthcare professional if symptoms continue.
About Dazzle Healthcare
Dazzle Healthcare is a trusted pharmaceutical and healthcare company offering quality healthcare formulations across multiple therapeutic segments.
The company provides a broad portfolio of diabetic, gastrointestinal, respiratory, nutritional, Ayurvedic, and pediatric healthcare products manufactured under quality-controlled pharmaceutical standards.
Dazzle Healthcare continues to strengthen its pharmaceutical presence through reliable products and professional franchise support.
PCD Pharma Franchise Opportunity for Dazmet-G1 Tablets
Dazmet-G1 Tablets are available for PCD pharma franchise opportunities across India through Dazzle Healthcare.
The diabetic healthcare segment continues to show strong demand across hospitals, clinics, pharmacies, and healthcare retail channels, making this product highly suitable for pharma franchise business expansion.
Franchise Benefits
- Monopoly rights
- Promotional support materials
- Attractive packaging
- Timely delivery support
- Strong diabetic healthcare demand
- Excellent business growth opportunities
Frequently Asked Questions
1. What are Dazmet-G1 tablets used for?
Dazmet-G1 tablets are used for blood sugar management and type 2 diabetes mellitus support.
2. What is the composition of Dazmet-G1 tablets?
They contain glimepiride 1 mg and metformin hydrochloride SR 500 mg.
3. What type of medicine is Dazmet-G1?
It is an anti-diabetic tablet formulation.
4. Can Dazmet-G1 tablets support blood sugar control?
Yes, they help support glycaemic balance and diabetic wellness.
5. What is the dosage form of Dazmet-G1 tablets?
They are available in tablet form.
6. How should Dazmet-G1 tablets be stored?
Store them in a cool and dry place away from sunlight.
7. Are Dazmet-G1 tablets suitable for long-term diabetic management?
Yes, they are commonly used for long-term diabetic care under medical supervision.
8. Are Dazmet-G1 tablets available for the PCD Pharma franchise?
Yes, they are available through Dazzle Healthcare for franchise opportunities.
9. What is the packing size of Dazmet-G1 tablets?
Dazmet-G1 tablets are available in 10×10 tablet packs.
10. Who manufactures Dazmet-G1 tablets?
They are manufactured by Dazzle Healthcare.
Conclusion
Dazmet-G1 Tablets are an advanced glimepiride and metformin SR anti-diabetic formulation designed to support blood sugar management, glycaemic balance, insulin sensitivity, and diabetic wellness. Its dual-action sustained-release formulation makes it a valuable healthcare solution for type 2 diabetes mellitus management.
With increasing demand for diabetic healthcare products, Dazmet-G1 Tablets continue to remain an important pharmaceutical solution offered by Dazzle Healthcare.
